ATE484753T1 - Hämatologie-blutkontrolle und verfahren zu ihrer herstellung - Google Patents

Hämatologie-blutkontrolle und verfahren zu ihrer herstellung

Info

Publication number
ATE484753T1
ATE484753T1 AT01930802T AT01930802T ATE484753T1 AT E484753 T1 ATE484753 T1 AT E484753T1 AT 01930802 T AT01930802 T AT 01930802T AT 01930802 T AT01930802 T AT 01930802T AT E484753 T1 ATE484753 T1 AT E484753T1
Authority
AT
Austria
Prior art keywords
blood control
producing same
cross
hematology blood
involve
Prior art date
Application number
AT01930802T
Other languages
English (en)
Inventor
Frank Carver
James Lapicola
Original Assignee
Bio Rad Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Rad Laboratories filed Critical Bio Rad Laboratories
Application granted granted Critical
Publication of ATE484753T1 publication Critical patent/ATE484753T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00—Reference solutions for assays of biological material
    • G01N2496/05—Reference solutions for assays of biological material containing blood cells or plasma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/101666—Particle count or volume standard or control [e.g., platelet count standards, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/107497—Preparation composition [e.g., lysing or precipitation, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT01930802T 2000-04-28 2001-04-26 Hämatologie-blutkontrolle und verfahren zu ihrer herstellung ATE484753T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20045100P 2000-04-28 2000-04-28
US09/816,911 US6514763B2 (en) 2000-04-28 2001-03-23 Hematology blood control and method for preparation of same
PCT/US2001/013464 WO2001084138A1 (en) 2000-04-28 2001-04-26 Hematology blood control and method for preparation of same

Publications (1)

Publication Number Publication Date
ATE484753T1 true ATE484753T1 (de) 2010-10-15

Family

ID=26895772

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01930802T ATE484753T1 (de) 2000-04-28 2001-04-26 Hämatologie-blutkontrolle und verfahren zu ihrer herstellung

Country Status (7)

Country Link
US (2) US6514763B2 (de)
EP (1) EP1279035B1 (de)
AT (1) ATE484753T1 (de)
AU (1) AU2001257305A1 (de)
CA (1) CA2407684C (de)
DE (1) DE60143261D1 (de)
WO (1) WO2001084138A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6514763B2 (en) * 2000-04-28 2003-02-04 Hematronix, Inc. Hematology blood control and method for preparation of same
US6916658B2 (en) * 2001-07-27 2005-07-12 Beckman Coulter, Inc. Method for measurement of immature granulocytes
EP1422509A1 (de) * 2002-11-01 2004-05-26 Streck Laboratories, Inc. Lysierungsreagenz und Verfahren zum Lysieren von Roten Blutkörperchen für die Hämatologie
JP4850711B2 (ja) * 2003-10-02 2012-01-11 ベックマン コールター， インコーポレイテッド 血液サンプルの有核赤血球の光学測定のリファレンスコントロール
US7198953B2 (en) * 2003-10-12 2007-04-03 Beckman Coulter, Inc. Method of using a reference control composition for measurement of nucleated red blood cells
US7195919B2 (en) * 2003-12-19 2007-03-27 Beckman Coulter, Inc. Hematology controls for reticulocytes and nucleated red blood cells
US7008792B2 (en) * 2004-02-10 2006-03-07 Beckman Coulter, Inc. Method of measurement of nucleated red blood cells
CN100376669C (zh) * 2005-02-25 2008-03-26 深圳迈瑞生物医疗电子股份有限公司 生物红细胞体积长期稳定的处理方法
US7531357B2 (en) * 2005-04-04 2009-05-12 Bio-Rad Laboratories, Inc. Preparation of platelet analogs
WO2008061073A2 (en) 2006-11-14 2008-05-22 Beckman Coulter, Inc. Hematology linearity control composition system and method of use
US7618821B2 (en) * 2007-04-13 2009-11-17 Streck, Inc. Simulated blood components and methods
CN101311724B (zh) * 2007-05-24 2014-11-12 深圳迈瑞生物医疗电子股份有限公司 单群白细胞模拟离子、包含单群白细胞模拟离子的校准物及其制备方法
CN101311725B (zh) 2007-05-25 2014-03-26 深圳迈瑞生物医疗电子股份有限公司 一种五分类白细胞质控物及其制备方法
CN101561443B (zh) * 2008-04-15 2013-08-21 深圳迈瑞生物医疗电子股份有限公司 五分类白细胞模拟物粒子、其制备方法以及含该模拟粒子的质控物和校准物
EP2216095A1 (de) * 2009-01-27 2010-08-11 Koninklijke Philips Electronics N.V. Mikrofluidische Vorrichtung für die Vollblutzählung
CN102334020B (zh) * 2011-01-11 2013-05-01 深圳西德赛科技有限公司 一种含有酯类化合物的血液流变质控组合物
JP6692834B2 (ja) 2015-02-09 2020-05-13 スリングショット バイオサイエンシーズ， インコーポレイテッド 調整可能な光学特性を有するヒドロゲル粒子およびその使用の方法
WO2018022991A1 (en) 2016-07-29 2018-02-01 Streck, Inc. Suspension composition for hematology analysis control
CN107478820B (zh) * 2017-07-18 2019-06-14 中国科学院苏州生物医学工程技术研究所 用于检测孢子丝菌病的血清凝集剂的制备方法
WO2019159866A1 (ja) * 2018-02-15 2019-08-22 花王株式会社 人毛繊維処理剤
KR20220129585A (ko) 2020-01-24 2022-09-23 슬링샷 바이오사이언시즈 인코포레이티드 세포-유사 보정 입자를 위한 조성물 및 방법
JP7807395B2 (ja) 2020-05-04 2026-01-27 スリングショット バイオサイエンシーズ， インコーポレイテッド 多重化アッセイのためのパッシブ光学バーコード付与のための組成物および方法
AU2022376541A1 (en) 2021-10-29 2024-04-18 Slingshot Biosciences, Inc. Hydrogel particles as feeder cells and as synthetic antigen presenting cells
CN119907921A (zh) 2022-05-05 2025-04-29 弹弓生物科学公司 用于血液学的作为红细胞模拟物的工程化颗粒和含有工程化颗粒的组合物
CA3257621A1 (en) 2022-06-02 2023-12-07 Slingshot Biosciences, Inc. APOPTOTIC CELL MIMETIC
CN120712108A (zh) 2022-10-26 2025-09-26 弹弓生物科学公司 具有可调整光学性质的大小可调整合成颗粒和用于使用其进行免疫细胞激活的方法
WO2025049609A1 (en) 2023-08-29 2025-03-06 Slingshot Biosciences, Inc. Cd34 stem cell mimics

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2656508A (en) 1949-08-27 1953-10-20 Wallace H Coulter Means for counting particles suspended in a fluid
US4099917A (en) 1977-07-21 1978-07-11 Technicon Instruments Corporation Process for preparing a cell suspension from blood for discrimination of white blood cells and platelets from other blood particles
US4286963A (en) 1979-11-23 1981-09-01 Coulter Electronics, Inc. Differential lymphoid-myeloid determination of leukocytes in whole blood
US5188935A (en) * 1984-05-31 1993-02-23 Coulter Electronics, Inc. Reagent system and method for identification, enumeration and examination of classes and subclasses of blood leukocytes
US4751179A (en) 1984-05-31 1988-06-14 Coulter Electronics, Inc. Method and reagents for differential determination of four populations of leukocytes in blood
IL85532A (en) * 1987-03-13 1992-03-29 Coulter Electronics Method and lytic reagent system for isolation,identification and/or analysis of leukocytes from whole blood samples
US5155044A (en) * 1987-03-13 1992-10-13 Coulter Electronics, Inc. Lysing reagent system for isolation, identification and/or analysis of leukocytes from whole blood samples
US5270208A (en) 1991-05-09 1993-12-14 Streck Laboratories, Inc. White blood cell hematology control
WO1996034283A1 (en) 1995-04-27 1996-10-31 Hematronix, Inc. Lytic system utilizing propionic acid for leukocytes differentiation
US5858790A (en) 1996-06-26 1999-01-12 Abbott Laboratories Hematology reference control and method of preparation
US6146901A (en) 1997-06-16 2000-11-14 Hematronix, Inc. Composition for manipulating optical and electrical properties of particles to achieve target values for such properties and methods for using the composition
US6514763B2 (en) * 2000-04-28 2003-02-04 Hematronix, Inc. Hematology blood control and method for preparation of same
US6653063B2 (en) * 2000-06-12 2003-11-25 Hematronix, Inc. Hematology composition using preserved white blood cells in combination with source particles to simulate native white blood cells and method of making same

Also Published As

Publication number Publication date
AU2001257305A1 (en) 2001-11-12
EP1279035A4 (de) 2006-01-04
US6762055B2 (en) 2004-07-13
US20010046708A1 (en) 2001-11-29
EP1279035B1 (de) 2010-10-13
US6514763B2 (en) 2003-02-04
CA2407684C (en) 2009-11-17
CA2407684A1 (en) 2001-11-08
DE60143261D1 (de) 2010-11-25
EP1279035A1 (de) 2003-01-29
US20030104631A1 (en) 2003-06-05
WO2001084138A1 (en) 2001-11-08

Similar Documents

Publication Publication Date Title
ATE484753T1 (de) Hämatologie-blutkontrolle und verfahren zu ihrer herstellung
DE60235995D1 (de) Aripiprazole Wirkstoff mit niedriger Hygroskopie und Verfahren zu ihrer Herstellung
DE60328421D1 (de) Verfahren zur herstellung von super-hydrophoben oberflächen, daraus hergestellte oberflächen und deren verwendung
DE60217203D1 (de) Poröse Teilchen, wässrige Dispersionen und Verfahren zu ihrer Herstellung
ATE307593T1 (de) Mit einem tensid co-mikronisiertes progestin, pharmazeutische zusammensetzung dieses enthaltend,verfahren zu deren herstellung sowie verwendung
DE502004012162D1 (de) Elektrosterisch stabilisierte wässrige polyurethan-harze, verfahren zu ihrer herstellung und deren verwendung
ATE426400T1 (de) Wirkstoffhaltige filmfírmige zubereitungen mit verbesserter chemischer stabilitat, und verfahren zu deren herstellung
DE69926030D1 (de) Verfahren zur vor Ort Herstellung eines desinfizierenden Peressigsäuresystems
DE60023868D1 (de) Methode und vorrichtung zur herstellung von schildern
ATE410459T1 (de) Bioabbaubare polyketale, verfahren zu ihrer herstellung sowie ihre verwendung
BRPI0115730B8 (pt) método de preparação de um material compreendendo um polímero hidrofílico, anfótero ou aniônico que possui atividade antimicrobiana
ATE297248T1 (de) Verfahren zur herstellung einer emulsion, deren organische phase eine hohe viskosität hat
ATE334682T1 (de) Verfahren zur herstellung von den trans-4-n- butylcyclohexanoicsaüre- und undecanoicsaüreestern von (7-alpha,11-beta)- dimethyl-17 beta -hydroxy-4-estren-3-one und deren medizynische anwendung
DK1329462T3 (da) Fremgangsmåde til fremstilling af human serumalbumin, som inddrager opvarmningstrin
DE60107756D1 (de) Wässrige, schnell trocknende Harzzusammensetzung und Verfahren zu ihrer Herstellung und Anwendung
DE602004026096D1 (de) Verfahren zur herstellung von polyacrolein
ATE344276T1 (de) Polyamidnukleinsäure-derivate, mittel und verfahren zur ihrer herstellung
DE602004014496D1 (de) Verwendung von ethanol als weichmacher zur herstellung von subkutanen implantaten , welche in einer plga matrize dispergierte thermolabile wirkstoffe enthalten
DE60032956D1 (de) Ionen-Selektivmembranen, Verfahren zu ihrer Herstellung, Anwendung von Ionen-Selektivmembranen und Vorrichtungen die Ionen-Selektivmembranen enthalten
SE0004928D0 (sv) A method for the manufacturing of porous material
ATE555811T1 (de) Verfahren zur herstellung von molekularkomplexen
DE60122725D1 (de) Organosiliciumverbindungen die polyorganosiloxane mit ethylenisch ungesättigten durch imidgruppen aktivierte gruppen enthalten und verfahren zur deren herstellung
WO2000032814A3 (en) Methods for producing selected interstrand cross-links in nucleic acids and applications thereof
DE60206056D1 (de) Herstellung von polymerteilchen
DE50111407D1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties